Associated tags: Physician, Patient, Medical device, Surgery, Bone, Medical Devices, Anatomy, Health, Regeneration, FDA, Elective surgery, Surgeon, Ankle, Medical Supplies, Hospitals, OSSIO, Arthrodesis, Foot, General Health, Immobilization
Locations: UNITED STATES, NORTH AMERICA, MASSACHUSETTS, BONE, NEW JERSEY, ISRAEL
Retrieved on:
Wednesday, December 6, 2023
Medical Devices,
FDA,
Health,
Technology,
Surgery,
Hardware,
Foot,
Arthrodesis,
Food,
Elective surgery,
Nail,
Anatomy,
Regeneration,
Risk,
Surgeon,
IPOS,
Immobilization,
Ankle,
Patient,
Multimedia,
GameChanger,
Fracture,
Ankle fracture,
American College,
DPM,
Child,
Anxiety,
Wrist,
Hand,
Trial of the century,
Trauma,
Knee,
Fibula,
Sports medicine,
Growth,
Parent,
ACFAS,
Medical device,
Dentistry,
Ceramic Key Points:
- View the full release here: https://www.businesswire.com/news/home/20231206064383/en/
The FDA has cleared the company’s OSSIOfiber® bio-integrative fixation technology for use in orthopedic surgery for children and adolescents needing bone fractures fixed, osteotomies, or fusions.
- As a result, OSSIOfiber Compression Screws and Trimmable Fixation Nails may now be used in children from age two to 21 years in standard clinical practice.
- Designed for rapid bone in-growth, regeneration and replacement, OSSIOfiber Intelligent Bone Regeneration Technology is a first-of-its-kind implant material stronger than cortical bone.
- It can address many surgical applications through the manufacturing of endless implant designs, including nails, screws, staples, anchors and plates.
Retrieved on:
Tuesday, February 7, 2023
Technology,
Surgery,
Medical Devices,
Medical Supplies,
Biotechnology,
Other Health,
Hardware,
Health,
General Health,
Elective surgery,
Fatigue,
Hand,
MTP,
Lapidus,
Anatomy,
Immobilization,
Patient,
Nickel,
Ankle,
CSA OrthoCarolina Sportsplex,
Pathology,
Arthrodesis,
Bone,
FDA,
Education,
Foot,
Regeneration,
Fracture,
Surgeon,
3D printing,
Medical device,
Medical imaging OSSIO , Inc., a fast-growing orthopedic fixation technology company, today announced the introduction of the new OSSIOfiber® Compression Staple, the next step towards becoming the gold standard in orthopedic fixation.
Key Points:
- OSSIO , Inc., a fast-growing orthopedic fixation technology company, today announced the introduction of the new OSSIOfiber® Compression Staple, the next step towards becoming the gold standard in orthopedic fixation.
- OSSIO’s fifth product family, OSSIOfiber® Compression Staples, allow surgeons to evolve to stronger, bio-integrative compression.
- OSSIOfiber® Compression Staples provide excellent stability and fixation, are stronger than many nitinol staples, and offer superior compression performance versus many widely used compression staples.
- “I used the staple for compression of a first MTP instead of a plate and it was fantastic,” said Dr. Parekh.
Medical Supplies,
Health,
Medical Devices,
Hospitals,
Surgery,
Health Technology,
General Health,
Adoption,
Physician,
Technology,
Anatomy,
Patient,
Regeneration,
MVM,
Forward-looking statement,
Bone,
Surgeon,
Medical device OSSIO , Ltd., a fast-growing orthopedic fixation technology company, announced today that it has closed $38.5 million in Series C financing.
Key Points:
- OSSIO , Ltd., a fast-growing orthopedic fixation technology company, announced today that it has closed $38.5 million in Series C financing.
- Specifically, we intend to use these funds to fortify new product development, sales force expansion, patient outreach and medical education.
- Dr. Reeders and his MVM colleague Dr. Kevin Cheng join OSSIOs board of directors as part of this financing.
- OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians and payors.
Biotechnology,
Medical Supplies,
Surgery,
General Health,
Health,
Medical Devices,
Hospitals,
Health Technology,
FDA,
Multimedia,
Elective surgery,
Surgeon,
Forward-looking statement,
Sport,
Technology,
All,
Trauma,
Regeneration,
Patient,
Nail,
Foot,
Safety,
Biology,
Physician,
Anatomy,
University,
Knee,
Sports medicine,
Bone,
Ankle,
Pediatrics,
Suture,
Shoulder,
Sports equipment,
Dentistry,
Medical imaging,
Silk,
Medical device OSSIO , Inc., a fast-growing orthopedic fixation technology company, announced today the U.S. launch and first commercial use of OSSIOfiber Suture Anchors, expanding patient access to the companys growing portfolio of bio-integrative implants for use in foot/ankle, shoulder, knee, hand/wrist and elbow surgery.
Key Points:
- OSSIO , Inc., a fast-growing orthopedic fixation technology company, announced today the U.S. launch and first commercial use of OSSIOfiber Suture Anchors, expanding patient access to the companys growing portfolio of bio-integrative implants for use in foot/ankle, shoulder, knee, hand/wrist and elbow surgery.
- View the full release here: https://www.businesswire.com/news/home/20220808005202/en/
The OSSIOfiber Suture Anchor is indicated for use in foot/ankle, shoulder, knee, hand/wrist and elbow surgery.
- This is another big step for OSSIOfiber in becoming a new material standard in orthopedic fixation.
- OSSIOfiber Suture Anchors were FDA cleared in March 2022 for use in fixation of suture (soft tissue) to bone in the shoulder, foot/ankle, knee, hand/wrist, and elbow in a variety of specific orthopedic procedures.
Medical Supplies,
Medical Devices,
FDA,
Health,
Hospitals,
Surgery,
Adoption,
Fracture,
Immobilization,
Forward-looking statement,
Bone,
Ankle,
Ascending limb of loop of Henle,
Nail,
Pediatrics,
Food,
Shoulder,
Hand,
Arthrodesis,
Anatomy,
Regeneration,
Surgeon,
Knee,
Physician,
Trauma,
Sport,
Elective surgery,
FDA,
Technology,
Patient,
Foot,
Pharmaceutical industry,
Medical device,
Feed manufacturing,
OSSIOFIBER® INTELLIGENT BONE REGENERATION TECHNOLOGY,
OSSIO FDA cleared March 2022 for use in fixation of suture (soft tissue) to bone in the shoulder, foot/ankle, knee, hand/wrist, and elbow in a variety of specific orthopedic procedures.
Key Points:
- FDA cleared March 2022 for use in fixation of suture (soft tissue) to bone in the shoulder, foot/ankle, knee, hand/wrist, and elbow in a variety of specific orthopedic procedures.
- FDA cleared January 2022 for use in fixation of arthrodesis, osteotomies and fractures in hand or foot surgery in the presence of appropriate brace and/or immobilization.
- Previously launched OSSIOfiber implants include the following compression screws, trimmable fixation nails and hammertoe fixation system:
OSSIOfiber Compression Screws.
- OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians and payors.
Retrieved on:
Tuesday, November 2, 2021
Surgery,
Health,
Medical Devices,
MD,
Research,
Technology,
American Orthopaedic Foot and Ankle Society,
Elective surgery,
Regeneration,
Adoption,
Patient,
Orthopedic surgery,
Faculty,
OFA,
Leadership,
Anatomy,
Â,
Maintenance,
Bone,
CEO,
Ohio State University,
Growth,
Sports medicine,
Education,
Immobilization,
AAOS,
American Academy,
Arthrodesis,
Ankle,
Physician,
Medical device,
Medicine,
OSSIOfiber® Intelligent Bone Regeneration Technology,
OSSIO,
OSSIOFIBER® INTELLIGENT BONE REGENERATION TECHNOLOGY,
OSSIO OSSIO, Inc., an orthopedic fixation technology company, today announced the appointment of Gregory C. Berlet, MD, as its Chief Medical Officer.
Key Points:
- OSSIO, Inc., an orthopedic fixation technology company, today announced the appointment of Gregory C. Berlet, MD, as its Chief Medical Officer.
- Dr. Berlet is a fellowship-trained orthopedic surgeon and nationally recognized leader in orthopedic research, education and product design.
- As Chief Medical Officer, he will provide critical clinical expertise, insight and guidance as we continue to scale our high-growth business for the future and elevate bio-integrative OSSIOfiber as the new standard of care in the field of orthopedic fixation."
- OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians and payors.
Comprised of proprietary OSSIOfiber Intelligent Bone Regeneration Technology, these compression screws are engineered to achieve the optimal balance of flexural, torque, axial and shear strength.
Key Points:
- Comprised of proprietary OSSIOfiber Intelligent Bone Regeneration Technology, these compression screws are engineered to achieve the optimal balance of flexural, torque, axial and shear strength.
- Additional procedures utilizing the OSSIOfiber Compression Screws are planned in limited markets in the coming weeks, with full commercialization in April.
- OSSIO plans to expand its compression screw portfolio in varying diameters, lengths and geometry to address additional extremity procedures as well as trauma cases in the near future.
- We are excited to partner with Courage Capital to achieve our aggressive growth plans, said Brian Verrier , CEO, OSSIO.
Health,
Medical devices,
Technology,
Other Technology,
Other Health,
General Health,
Biotechnology,
Metalworking,
Screw,
Woodworking,
Fixation,
OSSIOfiber® Intelligent Bone Regeneration Technology,
OSSIO This is the third FDA clearance for the companys OSSIOfiber Intelligent Bone Regeneration Technology, which uses proprietary bio-integrative material to provide stability and secure bone fixation while leaving no permanent hardware behind.
Key Points:
- This is the third FDA clearance for the companys OSSIOfiber Intelligent Bone Regeneration Technology, which uses proprietary bio-integrative material to provide stability and secure bone fixation while leaving no permanent hardware behind.
- OSSIOs Compression Screw Portfolio will initially comprise a 4.0mm-diameter cannulated, headless, partially threaded compression screw in lengths ranging from 26mm to 60mm.
- I look forward to adding this portfolio of innovative headless compression screws to my surgical repertoire.
- The company recently reached its 1,000th procedural milestone utilizing OSSIOfiber implants, including both the OSSIOfiber Hammertoe Fixation System and OSSIOfiber Trimmable Fixation Nail System.
OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, today announced the appointment of Gary J. Pruden to its Board of Directors.
Key Points:
- OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, today announced the appointment of Gary J. Pruden to its Board of Directors.
- "We are thrilled to welcome Gary to the OSSIO Board of Directors.
- Pruden also helped lead the J&J strategic collaboration with Google, which was established for the advancement of surgical robotics.
- Currently, Pruden serves in board management and strategic advisory roles for several start-up health companies including Motus GI Holdings, Orchestra BioMed and Lantheus Medical Imaging.
Medical devices,
FDA,
Health,
Surgery,
Clinical trials,
Biotechnology,
Medical specialties,
Surgery,
Medicine,
Bone fractures,
Arthropathies,
Hammer toe,
Orthopedic surgery,
Bone fracture,
Bone grafting,
Bone,
OSSIOfiber,
OSSIO OSSIO, Inc., an orthopedic fixation company, today announced that its OSSIOfiber Hammertoe Fixation System has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for maintenance of alignment and fixation of bone fractures, osteotomies, arthrodesis and bone grafts.
Key Points:
- OSSIO, Inc., an orthopedic fixation company, today announced that its OSSIOfiber Hammertoe Fixation System has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for maintenance of alignment and fixation of bone fractures, osteotomies, arthrodesis and bone grafts.
- The OSSIOfiber Hammertoe Fixation System comprises the companys breakthrough OSSIOfiber Intelligent Bone Regeneration Technology, a new category of fixation material that combines unparalleled mechanical strength and natural bone healing in a non-permanent implant.
- In 2019, OSSIO completed enrollment in its European multi-center clinical trial designed to assess the safety and performance of the OSSIOfiber Hammertoe Fixation System.
- These findings will serve to support OSSIOs Conformit Europene (CE) Mark application for approval of the OSSIOfiber Hammertoe Fixation System later this year.
